iBio Inc (IBIO)
1.69
-0.21
(-11.05%)
USD |
NYAM |
Apr 25, 16:00
1.69
0.00 (0.00%)
After-Hours: 20:00
iBio Gross Profit (Quarterly)
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
June 30, 2021 | 0.304M |
March 31, 2021 | 0.272M |
December 31, 2020 | 0.494M |
September 30, 2020 | 0.303M |
June 30, 2020 | 0.821M |
March 31, 2020 | 0.01M |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 |
Date | Value |
---|---|
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 0.3203M |
June 30, 2011 | 0.3441M |
March 31, 2011 | 0.176M |
December 31, 2010 | 0.00 |
September 30, 2010 | 0.00 |
June 30, 2010 | 0.00 |
March 31, 2010 | 0.00 |
December 31, 2009 | 0.00 |
September 30, 2009 | 0.00 |
June 30, 2009 | 0.1334M |
March 31, 2009 | 0.1605M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
0.01M
Minimum
Mar 2020
0.821M
Maximum
Jun 2020
0.3673M
Average
0.3035M
Median
Gross Profit (Quarterly) Benchmarks
Lixte Biotechnology Holdings Inc | -- |
PAVmed Inc | -0.562M |
Avalo Therapeutics Inc | 0.792M |
Imunon Inc | -- |
Ocugen Inc | -- |